# Oral Curcumin, Quercetin and Vitamin D3 Supplements for Mild to Moderate Symptoms of COVID-19

> **NCT04603690** · NA · COMPLETED · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 50 (actual)

## Conditions studied

- Covid-19

## Interventions

- **DIETARY_SUPPLEMENT:** Complementary therapy
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT04603690
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-16
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-02-28
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04603690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04603690, "Oral Curcumin, Quercetin and Vitamin D3 Supplements for Mild to Moderate Symptoms of COVID-19". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04603690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*